Although, the specific GLP-1R agonist Ex-4 has been reported to stimulate NSC viability and to counteract NSC apoptosis both in vitro and in vivo [48, 49], surprisingly, we could not achieve NSCs protection by Ex-4 in response to hypoglycaemia. This evidence concerns the gene GLP1R and Hypoglycemia.